Community Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Community Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$478.3 - $607.98 $345,332 - $438,961	-722 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$336.18 - $494.43 $243,058 - $357,472	-723 Reduced 50.03%	722 $353,000
Q3 2019 Nov 08, 2019	BUY	$273.46 - $318.39 $190,054 - $221,281	695 Added 92.67%	1,445 $401,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $42,789 - $50,550	115 Added 18.11%	750 $308,000
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $213,245 - $255,930	635 New	635 $237,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Community Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Community Capital Management, LLC with notifications on news.